Chemours Co. remains a well-positioned company in the chemical industry. Its strong financial performance, growth strategies, and market position make it an attractive investment opportunity for investors seeking exposure to the growing demand for high-performance chemicals.
Metric | 2023 | 2022 | Change |
---|---|---|---|
Revenue | $6.3 billion | $5.9 billion | 5.7% |
Net Income | $1.2 billion | $980 million | 23.4% |
Operating Cash Flow | $1.6 billion | $1.3 billion | 18.7% |
Customer | Industry | Revenue % |
---|---|---|
General Motors | Automotive | 12% |
Intel | Semiconductor | 10% |
BASF | Chemical | 8% |
PPG Industries | Construction | 7% |
Medtronic | Medical Devices | 6% |
Metric | 2024 (est.) | 2025 (est.) | CAGR |
---|---|---|---|
Revenue | $6.7 billion | $7.2 billion | 5.2% |
Net Income | $1.3 billion | $1.4 billion | 6.5% |
Earnings Per Share | $12.00 | $13.50 | 6.3% |
Analyst | Rating | Price Target |
---|---|---|
Goldman Sachs | Overweight | $65.00 |
JPMorgan | Neutral | $60.00 |
Bank of America | Buy | $63.00 |
Citigroup | Overweight | $62.00 |
Barclays | Neutral | $58.00 |
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-12-21 17:00:12 UTC
2024-12-30 16:28:39 UTC
2025-01-03 03:25:28 UTC
2025-01-05 17:30:26 UTC
2024-12-22 18:25:17 UTC
2024-12-31 20:03:59 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:36 UTC
2025-01-08 06:15:34 UTC
2025-01-08 06:15:33 UTC
2025-01-08 06:15:31 UTC
2025-01-08 06:15:31 UTC